Group One Trading
INZY

Group One Trading’s Inozyme Pharma INZY Stock Holding History

Group One Trading’s Portfolio INZY Stock Details INZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,400
Closed -$5.88K – 7767
2023
Q3 		$5.88K Buy
1,400
+700
+100% +$3.56K ﹤0.01% 6616
2023
Q2 		$3.9K Sell
700
-4,500
-87% -$26.6K ﹤0.01% 6827
2023
Q1 		$29.8K Buy
+5,200
New +$13.7K ﹤0.01% 5244

Group One Trading's INZY Position: Q2 2025 in Review

Group One Trading sold out of Inozyme Pharma (INZY) in Q2 2025, closing a stake of 3,715 shares — an estimated $9.2K sold.

Group One Trading first reported a position in INZY in Q1 2023 and held it in 8 quarters. The position peaked at $11.7K in Q2 2023. 86 funds tracked by Wall St. Rank hold INZY as of Q2 2025.

  • Group One Trading reported no remaining Inozyme Pharma position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 3,715 Inozyme Pharma shares in Q2 2025, an estimated $9.2K.
  • Group One Trading first reported a position in Inozyme Pharma in Q1 2023 and held it in 8 quarters.
  • Group One Trading's Inozyme Pharma position peaked at $11.7K in Q2 2023.
  • 86 funds tracked by Wall St. Rank held Inozyme Pharma as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.